Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis

• Status: Completed
• Trial end date: 2001-06-01
• Target enrollment: 0
• Participant gender: All

Summary

we hypothesize that PTX might be effective in lowering proteinuria by modulating renal MCP-1 production in human glomerulonephritis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Taiwan University Hospital
• Treatments: Pentoxifylline

Criteria

Inclusion Criteria:

• glomerular diseases with subnephrotic proteinuria

Exclusion Criteria:

• DM, hepatitis, systemic immunologic renal diseases